Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors

Serena S. Freeman, Steven W. Allen, Ramapriya Ganti, Jianrong Wu, Jing Ma, Xiaoping Su, Geoff Neale, Jeffrey S. Dome, Najat C. Daw, Joseph D. Khoury

Research output: Contribution to journalArticlepeer-review

92 Scopus citations


BACKGROUND. Osteosarcoma cell lines and tumors have been shown to express epidermal growth factor receptor (EGFR) and harbor amplifications at the EGFR locus. In this study, the authors further analyzed the genomic features of EGFR in osteosarcoma tumors and investigated whether they correlate with phosphatase and tensin homolog (PTEN) expression and copy number status. METHODS. EGFR and PTEN expression was assessed by immunohistochemistry (n = 28), and copy number alterations at the EGFR and PTEN loci were surveyed using Affymetrix (Santa Clara, Calif) 50K single nucleotide polymorphism (SNP) arrays (n = 31) and fluorescence in situ hybridization (FISH) (n = 27). The EGFR tyrosine kinase domain was sequenced to survey for activating mutations (n = 34). In addition, EGFRvlll expression was assessed using reverse transcriptase polymerase chain reaction (n = 24). Results were correlated with available clinical information on 59 patients, with a median age of 14.1 years (range, 5-23 years) and median follow-up of 4.4 years. RESULTS. EGFR expression was detected in the majority of osteosarcoma tumors surveyed (23 of 28; 82%). SNP arrays revealed evidence of frequent copy number gains at 7pll.2 and losses at 10q23.21. A sizeable subset (16 of 27 cases; 59%) showed gains at the EGFR locus using FISH (amplification in 4 of 27 [15%] and balanced chromosome 7 polysomy in 12 of 27 [44%]), and 12 cases showed deletions at the PTEN locus (biallelic deletions in 4 of 27 [15%] and monoallelic deletion in 9 of 27 [33%]). No activating mutations in the EGFR tyrosine kinase domain, EGFRvlll expression, or association with clinical findings were detected. CONCLUSIONS. EGFR expression and genomic gains at the EGFR locus are prevalent in osteosarcoma tumors, which also commonly harbor deletions at the PTEN

Original languageEnglish (US)
Pages (from-to)1453-1461
Number of pages9
Issue number6
StatePublished - Sep 15 2008
Externally publishedYes


  • Childhood cancer
  • EGFRvlll
  • Epidermal growth factor receptor
  • Osteosarcoma
  • PTEN
  • Single nucleotide polymorphism array
  • Tyrosine kinase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors'. Together they form a unique fingerprint.

Cite this